Streetbeat News

Revenues

BBBY

Bed Bath & Beyond has provided a Q3 2023 performance update, reporting over 4.8 million active customers as of September 4, 2023, a mid-single-digit percent net increase since its U.S. launch. The company also reported mid-single-digit percent growth in orders, a mid-teens percent decline in revenue, and a high-teens percent decline in average order value. Gross profit as a percent of revenue was approximately 18%, and sales & marketing expense as a percent of revenue was approximately 15%. The company has seen increased website visits and improved conversion since the U.S. launch.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:38 pm

SJ

Scienjoy Holding Corp expects its Q3 2023 total net revenues to be in the range of RMB330 million to RMB360 million. This forecast is based on current market and operational conditions, and may change due to potential impact of COVID-19 on the economy in China and other global markets.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:38 pm

XPOF

Xponential Fitness, Inc. (NYSE:XPOF) has issued its three-year operating targets ahead of its inaugural Analyst and Investor Day at the NYSE. The targets include 500 new studio openings, system-wide sales of $2.33 billion, revenue of $405 million, and adjusted EBITDA of $190 million. The company also announced a new partnership with Gympass and welcomed VaynerMedia as its official advertising agency.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:34 pm

ROKU

Roku, Inc has announced plans to reduce its workforce by 10% and has raised its third-quarter revenue guidance above consensus. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:33 pm

SPY

The USA trade balance for July was reported at -$65.00B, better than the estimated -$68.00B and the prior -$65.50B.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:30 pm

DERM

Journey Medical Corporation has entered an exclusive license agreement with Maruho Co., Ltd. for Qbrexza in South Korea and other Asian nations. The company will receive a $19M upfront payment and is eligible for certain milestones totaling up to $45M.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:09 pm

GH

Guardant Health (GH) has received coverage for its Guardant Reveal product from Geisinger Health Plan. This could potentially increase the accessibility and usage of the product, leading to increased revenues for Guardant Health.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:06 pm

AMRX

Amneal Pharmaceuticals has received approval from the FDA for its Abbreviated New Drug Application for Lisdexamfetamine Dimesylate Capsules in various dosages. This approval could potentially lead to increased revenues for the company.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:04 pm

CDTX

JNJ

Cidara Therapeutics announced that Janssen has elected to proceed under its license agreement relating to novel drug-Fc conjugates targeting influenza. Cidara will receive a $7M milestone payment and is eligible for an additional $685M.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:03 pm

NAAS

NaaS has received an energy storage order worth RMB204 million.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 11:13 am